Clarity Pharmaceuticals Ltd.

Last Updated:
4:10 pm
Friday, June 20, 2025
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Market Cap
AU$751.96M
Volume
6372811
Open
2.21
AU$
High
2.23
AU$
Low
2.01
AU$
Shares On Issue
317M
52 Week Low
1.43
AU$
52 Week High
8.975
AU$
Website
Sector
Healthcare
Medical Specialties
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.